Myelodysplastic Syndrome Trials
Leading Patient-Centric Strategies for Myelodysplastic Syndrome (MDS) Clinical Trials
Patient-centric clinical trials are a perfect complement to Myelodysplastic Syndrome (MDS) – a cancer affecting blood cells and bone marrow in patient populations 70 years and older. Without proper CRO guidance, studies that depend on patient involvement can lean toward the myopic, ignoring patient goals and feedback.
A patient-focused strategy highlights the needs and goals of the patient during the study, including quality of life, treatment management and survivability, and improved access options to trial participation.
Improving Patient Outcomes in MDS Trials
Biorasi is a strong advocate for integrating patient-centric solutions into clinical trials. We work collaboratively with sponsors, clinical sites, and other trial stakeholders to incorporate the “patient voice” into studies where it can improve efficiency and effectiveness:
- Remote solutions, including telemedicine, patient portals, and mobile device monitoring.
- Home care solutions, ranging from mobile vans and nurse visits to treatment logistics.
- Data solutions, incorporating real-world evidence and patient feedback through mobile technology.